Pharmabiz

Pulsenmore receives US FDA De Novo marketing authorization for Pulsenmore ES, a home-use prenatal ultrasound platform

Ramat Gan, Israel Wednesday, November 5, 2025, 12:00 Hrs [IST] ...
Pharmabiz

Mumbai EOW initiates probe against Medikabazaar current board members and partners for corporate fraud

Mumbai EOW initiates probe against Medikabazaar current board members and partners for corporate fraud: Our Bureau, Mumbai Wednesday, November 5, 2025, 16:15 Hrs [IST] The Economi ...
Pharmabiz

Valneva reports positive results for phase 1 trial of second generation Zika vaccine candidate, VLA1601

Valneva reports positive results for phase 1 trial of second generation Zika vaccine candidate, VLA1601: Saint-Herblain, France Wednesday, November 5, 2025, 16:00 Hrs [IST] Valnev ...
Pharmabiz

Merck inks pact with Dr Falk Pharma to discontinue certain development and commercialization rights to MK-8690, an investigational anti-CD30 ligand mAb

Merck inks pact with Dr Falk Pharma to discontinue certain development and commercialization rights to MK-8690, an investigational anti-CD30 ligand mAb: Rahway, New Jersey Wednesd ...
Pharmabiz

Cipla acquires Inzpera Healthsciences in a deal heralding pharma's new era of empathetic innovation

Cipla acquires Inzpera Healthsciences in a deal heralding pharma's new era of empathetic innovation: Our Bureau, Chennai Wednesday, November 5, 2025, 13:50 Hrs [IST] Pharmaceutica ...
Pharmabiz

Mobisoft Infotech optimizes medical transportation for chronic care patients with an advanced NEMT solution

Mobisoft Infotech optimizes medical transportation for chronic care patients with an advanced NEMT solution: Our Bureau, Bengaluru Wednesday, November 5, 2025, 13:40 Hrs [IST] Mob ...
Pharmabiz

Novavax completes US marketing authorization transfer to Sanofi for Nuvaxovid

US marketing authorization for its Covid-19 vaccine, Nuvaxovid to Sanofi, enabling Sanofi to take full responsibility for commercial and regulatory activities in the US and fulfilling part of its ...
Pharmabiz

US FDA grants 510(k) clearance to QuidelOrtho’s VITROS hs Troponin I Assay

US FDA grants 510(k) clearance to QuidelOrtho’s VITROS hs Troponin I Assay: San Diego Tuesday, November 4, 2025, 18:00 Hrs ...
Pharmabiz

Ajanta Pharma net profit up by 20%, interim dividend of Rs. 28 per share

Ajanta Pharma net profit up by 20%, interim dividend of Rs. 28 per share: Our Bureau, Mumbai Wednesday, November 5, 2025, 13:10 Hrs [IST] Ajanta Pharma, a Rs. 4,600 crore plus pha ...
Pharmabiz

Metropolis Healthcare revenues jump by 23% in Q2, interim dividend of 200%

Metropolis Healthcare revenues jump by 23% in Q2, interim dividend of 200%: Our Bureau, Mumbai Wednesday, November 5, 2025, 13:20 Hrs [IST] Metropolis Healthcare, India’s second ...
Pharmabiz

New NIHR Research Professors to tackle urgent health challenges

New NIHR Research Professors to tackle urgent health challenges: United Kingdom Wednesday, November 5, 2025, 13:00 Hrs [IST] The NIHR has announced 6 new outstanding leaders to be ...
Pharmabiz

Pfizer files federal antitrust claims in second lawsuit against Metsera, its controlling stockholders and Novo Nordisk

Pfizer files federal antitrust claims in second lawsuit against Metsera, its controlling stockholders and Novo Nordisk: New York Wednesday, November 5, 2025, 10:00 Hrs [IST] Pfize ...